Skip to content
  • Home
    • Journal information
    • Editorial board
    • Operations manual
    • Editorial policies
    • Code of conduct for authors
    • Code of conduct for reviewers
  • Ahead of print
  • Read
    • Archive
    • TOC Alert
    • Current issue
  • Information
    • Editorial & Peer Review
    • Ethical policies
    • Funding
    • Complaints and appeals
    • Open access and licensing
    • Authors
    • Sponsorship
    • Contact
  • Publish
    • Instructions to authors
    • Online submission
  • Español
  • English
  • Home
    • Journal Information
    • Editorial Board
    • Operations Manual
    • Editorial Polices
    • Code of conduct for authors
    • Code of conduct for reviewers
  • Ahead of print
  • Read
    • Archive
    • Toc Alert
    • Current issue
  • Information
    • Editorial & Peer review
    • Ethical policies
    • Funding
    • Procedure for complaints and/or appeals
    • Open access & Licensing
    • Authors
    • Sponsors
    • Contact
  • Publish
    • Authors Instructions
    • Online submission
  • Home
    • Journal Information
    • Editorial Board
    • Operations Manual
    • Editorial Polices
    • Code of conduct for authors
    • Code of conduct for reviewers
  • Ahead of print
  • Read
    • Archive
    • Toc Alert
    • Current issue
  • Information
    • Editorial & Peer review
    • Ethical policies
    • Funding
    • Procedure for complaints and/or appeals
    • Open access & Licensing
    • Authors
    • Sponsors
    • Contact
  • Publish
    • Authors Instructions
    • Online submission
  • ES
  • EN
  • TOC Alert

Author: creacionmx

Clinical application of molecular diagnostics in myeloid disorders: recommendations for implementing a common strategy in Spanish centers

  

Hematologic dysregulation as a sign of inborn errors of immunity: activated PI3Kδ syndrome (APDS) as a model

  

Chronic lymphocytic leukemia: recommendations for next-generation sequencing

  

64-year-old male with constitutional symptoms and pancytopenia

  

Regarding rebalancing therapies: what is Concizumab® contribution?

  

Corrigendum

  

Journal of a transfusion center in times of COVID-19

  

Acute myeloid leukemia: recommendations for next-generation sequencing

  

69-year-old patient with anemia and massive splenomegaly

  

Artificial intelligence in the diagnosis of hematologic diseases

  

← previous
Next →
PERMANYER
  • permanyer@permanyer.com
  • www.permanyer.com

Mallorca, 310
08037, Barcelona (España)

Arquímedes, 190 – Colonia Polanco
Delegación Miguel Hidalgo
11560, Ciudad de México (México)

RECURRING LINKS
  • Current Issue
  • Ahead of Print
  • Archive
  • Online submission
  • Contact
CLOCKSS is a dak archive that ensures the long-term survival of web-based scholary publications, governed by and for its stakeholders.
  • Copyright 2026
  • Legal Notice
  • Permissions & Reprints
  • Data Protection Policy
  • Ethics Code
  • Conflicts of Interest